INVESTCORP AI ACQUISITION CO (IVCA) Stock Fundamental Analysis

NASDAQ:IVCA • KYG492191013

12 USD
-0.09 (-0.74%)
At close: May 7, 2025
11.5 USD
-0.5 (-4.17%)
After Hours: 5/7/2025, 8:13:16 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

Overall IVCA gets a fundamental rating of 1 out of 10. We evaluated IVCA against 0 industry peers in the Unkown industry. Both the profitability and financial health of IVCA have multiple concerns. IVCA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • IVCA had positive earnings in the past year.
  • IVCA had a negative operating cash flow in the past year.
IVCA Yearly Net Income VS EBIT VS OCF VS FCFIVCA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 2M -2M 4M 6M 8M

1.2 Ratios

Industry RankSector Rank
ROA 22.57%
ROE 31.64%
ROIC N/A
ROA(3y)3.56%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IVCA Yearly ROA, ROE, ROICIVCA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 2 4 6 8

1.3 Margins

  • IVCA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IVCA Yearly Profit, Operating, Gross MarginsIVCA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • The number of shares outstanding for IVCA has been reduced compared to 1 year ago.
  • The debt/assets ratio for IVCA is higher compared to a year ago.
IVCA Yearly Shares OutstandingIVCA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M
IVCA Yearly Total Debt VS Total AssetsIVCA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

  • An Altman-Z score of 10.65 indicates that IVCA is not in any danger for bankruptcy at the moment.
  • IVCA has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 10.65
ROIC/WACCN/A
WACCN/A
IVCA Yearly LT Debt VS Equity VS FCFIVCA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • IVCA has a Current Ratio of 0.03. This is a bad value and indicates that IVCA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • A Quick Ratio of 0.03 indicates that IVCA may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
IVCA Yearly Current Assets VS Current LiabilitesIVCA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 500K 1M 1.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • IVCA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.28%.
EPS 1Y (TTM)-26.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-139.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 50.00, IVCA can be considered very expensive at the moment.
  • Compared to an average S&P500 Price/Earnings ratio of 27.13, IVCA is valued quite expensively.
Industry RankSector Rank
PE 50
Fwd PE N/A
IVCA Price Earnings VS Forward Price EarningsIVCA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IVCA Per share dataIVCA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • IVCA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

INVESTCORP AI ACQUISITION CO

NASDAQ:IVCA (5/7/2025, 8:13:16 PM)

After market: 11.5 -0.5 (-4.17%)

12

-0.09 (-0.74%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)04-16
Earnings (Next)N/A
Inst Owners119.36%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap95.28M
Revenue(TTM)N/A
Net Income(TTM)3.89M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 50
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 7.74
P/tB 7.74
EV/EBITDA N/A
EPS(TTM)0.24
EY2%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0
BVpS1.55
TBVpS1.55
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 22.57%
ROE 31.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)3.56%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z 10.65
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-139.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y11.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y68.17%
OCF growth 3YN/A
OCF growth 5YN/A

INVESTCORP AI ACQUISITION CO / IVCA FAQ

What is the ChartMill fundamental rating of INVESTCORP AI ACQUISITION CO (IVCA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to IVCA.


Can you provide the valuation status for INVESTCORP AI ACQUISITION CO?

ChartMill assigns a valuation rating of 0 / 10 to INVESTCORP AI ACQUISITION CO (IVCA). This can be considered as Overvalued.


How profitable is INVESTCORP AI ACQUISITION CO (IVCA) stock?

INVESTCORP AI ACQUISITION CO (IVCA) has a profitability rating of 0 / 10.